Polyunsaturated fatty acids in heart failure: should we give more and give earlier?
- PMID: 21215549
- PMCID: PMC3069620
- DOI: 10.1016/j.jacc.2010.11.014
Polyunsaturated fatty acids in heart failure: should we give more and give earlier?
Figures
Comment on
-
Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy.J Am Coll Cardiol. 2011 Feb 15;57(7):870-9. doi: 10.1016/j.jacc.2010.11.017. Epub 2011 Jan 6. J Am Coll Cardiol. 2011. PMID: 21215550 Clinical Trial.
References
-
- Fonarow GC, Yancy CW, Albert NM, et al. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail. 2008;1:98–106. - PubMed
-
- Bang HO, Dyerberg J. Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med Scand. 1972;192:85–94. - PubMed
-
- Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases. J Am Coll Cardiol. 2009;54:585–594. - PubMed
-
- Witte KK, Clark AL. Marine polyunsaturated fatty acids in heart failure: Are the theoretical benefits matched by the clinical data? Pol Arch Med Wewn. 2009;119(3):162–169. - PubMed
-
- Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447–455. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
